Corrigendum: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

Front Oncol. 2019 Sep 27:9:990. doi: 10.3389/fonc.2019.00990. eCollection 2019.

Authors

Hanbo Cao¹, Wenjun Li¹, Yizhou Zhou¹, Renxiang Tan², Yue Yang¹, You Zhou¹, Qinglong Guo¹, Li Zhao¹

Affiliations

¹ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing, China.
² State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2019.00188.].

Keywords: CXCL12/CXCR4; Imatinib (IM); bone marrow environment; oroxylin A; β-catenin/P-gp.

Copyright © 2019 Cao, Li, Zhou, Tan, Yang, Zhou, Guo and Zhao.

Publication types

Published Erratum